SYSMHC00055_HLAIIp_CRC-01 | 2 | Human | DRB1_0401,DRB4_0103 | ||
SYSMHC00055_HLAIIp_CRC-01_IFN | 10 | Human | DRB1_0401,DRB4_0103 | ||
SYSMHC00055_HLAIIp_CRC-01_TRAM | 8 | Human | DRB1_0401,DRB4_0103 | ||
SYSMHC00055_HLAIIp_CRC-03 | 6 | Human | no allele | ||
SYSMHC00055_HLAIIp_CRC-04 | 6 | Human | DRB1_1101,DRB1_0301,DRB3_0202 | ||
SYSMHC00055_HLAIIp_CRC-04_IFN | 8 | Human | DRB1_1101,DRB1_0301,DRB3_0202 | ||
SYSMHC00055_HLAIIp_CRC-04_TRAM | 7 | Human | DRB1_1101,DRB1_0301,DRB3_0202 | ||
SYSMHC00055_HLAIIp_CRC-05 | 2 | Human | DRB1_0404 | ||
SYSMHC00055_HLAIIp_CRC-05_IFN | 6 | Human | DRB1_0404 | ||
SYSMHC00055_HLAIIp_CRC-05_TRAM | 8 | Human | DRB1_0404 | ||
SYSMHC00055_HLAIIp_CRC-08 | 4 | Human | DRB1_0404 | ||
SYSMHC00055_HLAIIp_CRC-08_IFN | 12 | Human | DRB1_0404 | ||
SYSMHC00055_HLAIIp_CRC-08_TRAM | 8 | Human | DRB1_0404 | ||
SYSMHC00055_HLAIp_CRC-01 | 4 | Human | HLA-A31_01,HLA-A32_01,HLA-B14_01,HLA-B27_05,HLA-C02_02,HLA-C08_02 | ||
SYSMHC00055_HLAIp_CRC-01_IFN | 10 | Human | HLA-A31_01,HLA-A32_01,HLA-B14_01,HLA-B27_05,HLA-C02_02,HLA-C08_02 | ||
SYSMHC00055_HLAIp_CRC-01_TRAM | 8 | Human | HLA-A31_01,HLA-A32_01,HLA-B14_01,HLA-B27_05,HLA-C02_02,HLA-C08_02 | ||
SYSMHC00055_HLAIp_CRC-03 | 6 | Human | HLA-A02_01,HLA-A29_02,HLA-B15_01,HLA-B44_03,HLA-C03_04,HLA-C16_01 | ||
SYSMHC00055_HLAIp_CRC-04 | 6 | Human | HLA-A03_01,HLA-A24_02,HLA-B18_01,HLA-B35_08,HLA-C04_01,HLA-C05_01 | ||
SYSMHC00055_HLAIp_CRC-04_IFN | 8 | Human | HLA-A03_01,HLA-A24_02,HLA-B18_01,HLA-B35_08,HLA-C04_01,HLA-C05_01 | ||
SYSMHC00055_HLAIp_CRC-04_TRAM | 3 | Human | HLA-A03_01,HLA-A24_02,HLA-B18_01,HLA-B35_08,HLA-C04_01,HLA-C05_01 | ||
SYSMHC00055_HLAIp_CRC-05 | 4 | Human | HLA-A32_01,HLA-B40_01,HLA-C03_04 | ||
SYSMHC00055_HLAIp_CRC-05_IFN | 6 | Human | HLA-A32_01,HLA-B40_01,HLA-C03_04 | ||
SYSMHC00055_HLAIp_CRC-05_TRAM | 8 | Human | HLA-A32_01,HLA-B40_01,HLA-C03_04 | ||
SYSMHC00055_HLAIp_CRC-08 | 6 | Human | HLA-A03_01,HLA-A29_01,HLA-B35_03,HLA-B44_02,HLA-C04_01,HLA-C05_01 | ||
SYSMHC00055_HLAIp_CRC-08_IFN | 10 | Human | HLA-A03_01,HLA-A29_01,HLA-B35_03,HLA-B44_02,HLA-C04_01,HLA-C05_01 | ||
SYSMHC00055_HLAIp_CRC-08_TRAM | 8 | Human | HLA-A03_01,HLA-A29_01,HLA-B35_03,HLA-B44_02,HLA-C04_01,HLA-C05_01 |
SYSMHC00055 | SYSMHC00055_HLAIIp_CRC-01_IFN | 20180824_QE_HFX_LC2_SA_JMI_HLAIIp_CRC-01_TRAM1_R01.raw | In vitro | suspension | Colorectal carcinoma | class II | 31735170 | native | Immunoaffinity | TV39 | Q-Exactive | Easy-nLC | no | DDA | HCD | 1 | ||||||||
SYSMHC00055 | SYSMHC00055_HLAIIp_CRC-01_IFN | 20180824_QE_HFX_LC2_SA_JMI_HLAIIp_CRC-01_IFN5_R02.raw | In vitro | suspension | Colorectal carcinoma | class II | 31735170 | native | Immunoaffinity | TV39 | Q-Exactive | Easy-nLC | no | DDA | HCD | 2 | ||||||||
SYSMHC00055 | SYSMHC00055_HLAIIp_CRC-01_IFN | 20180824_QE_HFX_LC2_SA_JMI_HLAIIp_CRC-01_IFN5_R01.raw | In vitro | suspension | Colorectal carcinoma | class II | 31735170 | native | Immunoaffinity | TV39 | Q-Exactive | Easy-nLC | no | DDA | HCD | 3 | ||||||||
SYSMHC00055 | SYSMHC00055_HLAIIp_CRC-01_IFN | 20180824_QE_HFX_LC2_SA_JMI_HLAIIp_CRC-01_IFN4_R02.raw | In vitro | suspension | Colorectal carcinoma | class II | 31735170 | native | Immunoaffinity | TV39 | Q-Exactive | Easy-nLC | no | DDA | HCD | 4 | ||||||||
SYSMHC00055 | SYSMHC00055_HLAIIp_CRC-01_IFN | 20180824_QE_HFX_LC2_SA_JMI_HLAIIp_CRC-01_IFN1_R02.raw | In vitro | suspension | Colorectal carcinoma | class II | 31735170 | native | Immunoaffinity | TV39 | Q-Exactive | Easy-nLC | no | DDA | HCD | 5 | ||||||||
SYSMHC00055 | SYSMHC00055_HLAIIp_CRC-01_IFN | 20180824_QE_HFX_LC2_SA_JMI_HLAIIp_CRC-01_IFN2_R02.raw | In vitro | suspension | Colorectal carcinoma | class II | 31735170 | native | Immunoaffinity | TV39 | Q-Exactive | Easy-nLC | no | DDA | HCD | 6 | ||||||||
SYSMHC00055 | SYSMHC00055_HLAIIp_CRC-01_IFN | 20180824_QE_HFX_LC2_SA_JMI_HLAIIp_CRC-01_IFN2_R01.raw | In vitro | suspension | Colorectal carcinoma | class II | 31735170 | native | Immunoaffinity | TV39 | Q-Exactive | Easy-nLC | no | DDA | HCD | 7 | ||||||||
SYSMHC00055 | SYSMHC00055_HLAIIp_CRC-01_IFN | 20180824_QE_HFX_LC2_SA_JMI_HLAIIp_CRC-01_IFN1_R01.raw | In vitro | suspension | Colorectal carcinoma | class II | 31735170 | native | Immunoaffinity | TV39 | Q-Exactive | Easy-nLC | no | DDA | HCD | 8 | ||||||||
SYSMHC00055 | SYSMHC00055_HLAIIp_CRC-01_IFN | 20180824_QE_HFX_LC2_SA_JMI_HLAIIp_CRC-01_TRAM1_R02.raw | In vitro | suspension | Colorectal carcinoma | class II | 31735170 | native | Immunoaffinity | TV39 | Q-Exactive | Easy-nLC | no | DDA | HCD | 9 | ||||||||
SYSMHC00055 | SYSMHC00055_HLAIIp_CRC-01_IFN | 20180824_QE_HFX_LC2_SA_JMI_HLAIIp_CRC-01_IFN5_R02.raw | In vitro | suspension | Colorectal carcinoma | class II | 31735170 | native | Immunoaffinity | TV39 | Q-Exactive | Easy-nLC | no | DDA | HCD | 10 |